Articles Featuring All Things Allergy, Autoimmunity, & Anti-inflammatory Living

Written by Dr. Kara Wada

Why Healthcare Is FAILING You: A Doctor Roundtable on Chronic Illness

Why Healthcare Is FAILING You: A Doctor Roundtable on Chronic Illness

Why Healthcare Is FAILING You: A Doctor Roundtable on Chronic IllnessDr. Kara Wada
Published on: 09/09/2025

In this Virtual Sjogren's Summit roundtable, doctors discuss why the 15-min model fails chronic illness patients (Sjogren's, Dysautonomia, MCAS) & how to advocate for better care.

Advocacy & Empowerment
Dazodalibep vs. Nipocalimab: Patient Perspectives on Sjogren's Clinical Trials

Dazodalibep vs. Nipocalimab: Patient Perspectives on Sjogren's Clinical Trials

Dazodalibep vs. Nipocalimab: Patient Perspectives on Sjogren's Clinical TrialsDr. Kara Wada
Published on: 03/09/2025

Dr. Kara Wada and Janet Steins share candid patient experiences in Sjogren's clinical trials (Dazodalibep, Nipocalimab), discussing challenges, benefits, and hopes for the future.

Sjogren's
MCAS vs. Allergies: Clearing Up the Confusion (and Why It Matters for Your Health!)

MCAS vs. Allergies: Clearing Up the Confusion (and Why It Matters for Your Health!)

MCAS vs. Allergies: Clearing Up the Confusion (and Why It Matters for Your Health!)Dr. Kara Wada
Published on: 27/08/2025

Understand the key differences between MCAS (Mast Cell Activation Syndrome) and traditional allergies, why diagnosis is tricky, and how to advocate for answers.

Allergy & Immunology
Breaking News for Sjogren’s Disease: Ianalumab Phase 3 Trials Are SUCCESSFUL!

Breaking News for Sjogren’s Disease: Ianalumab Phase 3 Trials Are SUCCESSFUL!

Breaking News for Sjogren’s Disease: Ianalumab Phase 3 Trials Are SUCCESSFUL!Dr. Kara Wada
Published on: 21/08/2025

Huge milestone for Sjogren's Disease! Learn about ianalumab's successful Phase 3 trials, how it works, and what it means for the future of Sjogren's treatment.

Sjogren's

© 2025 Dr Kara Wada. All Rights Reserved.